• EZ Cap™ Cas9 mRNA (m1Ψ): Boosting Editing Precision and Effi

  2026-07-03

  EZ Cap™ Cas9 mRNA (m1Ψ) sets a new standard for CRISPR genome editing, combining Cap1 capping, m1Ψ modification, and poly(A) tailing for superior stability and translation in mammalian cells. This advanced mRNA solution from APExBIO empowers researchers to achieve high-efficiency, low-immunogenicity editing, while integrating seamlessly with the latest specificity control strategies.

• WP1066, JAK2/STAT3 Inhibitor: Advanced Cancer & Regeneration

  2026-07-02

  WP1066, a potent cell-permeable JAK2/STAT3 inhibitor, enables precise modulation of cancer signaling pathways and macrophage immunometabolism. This guide bridges advanced protocol design, troubleshooting, and translational applications in oncology and bone repair.

• Salvianolic Acid B: Applied Protocols for Pulmonary Fibrosis

  2026-07-02

  Salvianolic acid B propels fibrosis research with validated, LH2-targeted workflows that enhance reproducibility and mechanistic clarity. This guide translates the latest advances into actionable protocols, troubleshooting, and comparative insights for extracellular matrix remodeling studies.

• Co-targeting BRD4 and RAC1 Disrupts c-MYC Axis in Breast Can

  2026-07-01

  This study demonstrates that simultaneous inhibition of BET bromodomain BRD4 and RAC1 signaling effectively suppresses tumor growth, stemness, and tumorigenic potential in diverse breast cancer subtypes. Mechanistically, this co-targeting strategy disrupts the c-MYC-G9a-FTH1 axis and downregulates HDAC1, revealing new avenues for epigenetic interventions in cancer.

• Methicillin Sodium Salt: Precision Tools for MSSA Infection

  2026-07-01

  Methicillin sodium salt (APExBIO C3238) remains the gold-standard bacterial cell wall synthesis inhibitor for MSSA infection research and antibiotic resistance modeling. This article translates recent evidence and best practices into actionable workflows, troubleshooting guidance, and strategic insights for robust Staphylococcus aureus research.

• Puerarin Drives Osteogenic Differentiation via Nitric Oxide

  2026-06-30

  The referenced study demonstrates that puerarin significantly enhances osteogenic differentiation of rat dental follicle cells (rDFCs) through activation of the nitric oxide (NO) pathway. This mechanistic insight suggests new avenues for periodontal tissue regeneration and reveals how NOS pathway modulation is integral to stem cell-based dental therapies.

• Arachidonic Acid: Optimizing Eicosanoid Workflows in Inflamm

  2026-06-30

  Arachidonic acid is the linchpin for modeling eicosanoid biosynthesis and lipid signaling, enabling high-fidelity neuroinflammation and vascular response assays. This guide details advanced experimental workflows, troubleshooting strategies, and actionable tips using APExBIO’s premium-grade Arachidonic Acid, bridging bench research to translational breakthroughs in stroke and immune studies.

• WP1066, JAK2/STAT3 Inhibitor: Protocols and Research Advanta

  2026-06-29

  WP1066 is redefining JAK2/STAT3 pathway research with robust antiproliferative and pro-apoptotic activity in cancer and regenerative models. This guide details applied workflows, troubleshooting, and how to leverage WP1066 for advanced oncologic and immunometabolic investigations.

• MLN8237 (Alisertib): Targeting Aurora A in High-Risk Oncolog

  2026-06-29

  Explore how MLN8237 (Alisertib), a selective Aurora A kinase inhibitor, advances cancer research by specifically targeting high-risk tumor biology. This article uniquely dissects recent insights into retinoblastoma and practical assay implications.

• Resveratrol’s Hormetic Rescue of Radiation-Induced Endotheli

  2026-06-28

  This study established an in vitro endothelial model to quantify radiation-induced vascular injury and demonstrated that resveratrol exerts a hormetic, dose-dependent protective effect. The findings clarify resveratrol’s unique role in rescuing, rather than preventing, endothelial tube formation and DNA integrity following ionizing radiation exposure.

• SD 169 (indole-5-carboxamide) for p38 MAPK Pathway Modulatio

  2026-06-27

  SD 169 (indole-5-carboxamide) stands out as a selective ATP-competitive inhibitor for precise p38 MAPK pathway modulation in inflammation, type 1 diabetes, and neuroregeneration assays. Its dual-action mechanism, revealed in recent structural studies, enables both robust kinase inhibition and accelerated dephosphorylation—offering improved specificity and reproducibility for advanced experimental workflows.

• Azithromycin as a Selective Senolytic in Human Fibroblasts

  2026-06-26

  The referenced study reveals that the macrolide antibiotic Azithromycin selectively eliminates senescent human fibroblasts, uncovering a new senolytic drug class. This finding, supported by robust in vitro assays, suggests repurposing opportunities for Azithromycin beyond bacterial infection research, with implications for aging and cell senescence studies.

• ATRX-Deficient Glioma Sensitivity to RTK and PDGFR Inhibitor

  2026-06-26

  This study demonstrates that high-grade glioma cells lacking ATRX are significantly more sensitive to multi-targeted receptor tyrosine kinase (RTK) and PDGFR inhibitors. The findings suggest that integrating ATRX mutation status could refine targeted therapy strategies and inform clinical trial design in aggressive glioma research.

• Oligomycin A: Mitochondrial ATP Synthase Inhibitor in Cancer

  2026-06-25

  Oligomycin A is a benchmark mitochondrial ATP synthase inhibitor, empowering advanced research into metabolic adaptation and immunometabolic checkpoints in cancer. This article details optimized protocols, troubleshooting, and innovative applications for dissecting mitochondrial bioenergetics and apoptosis pathways with APExBIO’s trusted reagent.

• Sex Differences in Angiotensin II-Induced Hypertension in Mi

  2026-06-25

  This study provides the first evidence that male and female mice exhibit distinct blood pressure responses to chronic angiotensin II infusion, with males developing a more pronounced hypertension. These findings underscore the critical role of sex hormones and autonomic regulation in hypertension models, guiding future cardiovascular research toward sex-specific mechanisms.

443 records 12/30 page Previous Next First page 上5页 1112131415 下5页 Last page